Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-06

FDA Approved: TICAGRELOR — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

The FDA approved Lifestar Pharma LLC's original ANDA for ticagrelor, a P2Y12 receptor inhibitor used to reduce thrombotic cardiovascular events in certain acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

ORIG AP for TICAGRELOR (TICAGRELOR)